Intercure Ltd. (INCR) Financials
INCR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 228.2 million | 85.2 million |
2023-03-31 | 266.2 million | 121.3 million |
2022-12-31 | 248.6 million | 100.1 million |
2022-09-30 | 246.1 million | 101.7 million |
INCR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | 257221 | 257221 |
2023-03-31 | 10.7 million | 759882 |
2022-12-31 | 10.9 million | 776545 |
2022-09-30 | 270099 | 1.0 million |
INCR Net Income
No data available :(
INCR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 27.9 million | - | 5.8 million |
2023-03-31 | 64.7 million | - | 6.2 million |
2022-12-31 | 30.3 million | - | 7.8 million |
2022-09-30 | 60.6 million | - | 5.5 million |
INCR Shares Outstanding
INCR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 1031 | 26833 | 3.1 million | 3.9 million |
2023-03-31 | 1.3 million | 48343 | 16.2 million | 9.8 million |
2022-12-31 | 1.3 million | 49403 | 16.6 million | 10.0 million |
2022-09-30 | 1.2 million | 33762 | 3.9 million | 4.7 million |
INCR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 27.8 million | 18.9 million |
2023-03-31 | 29.3 million | 22.2 million |
2022-12-31 | 30.0 million | 22.6 million |
2022-09-30 | 28.3 million | 15.3 million |
INCR
Price: $2.66
52 week price:
Earnings Per Share: 0.12 USD
P/E Ratio: 12
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 6941
Ebitda: 98.4 millionMarket Capitalization: 107.6 million